• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Announcements

8.82% ! 15.5¢
Market Cap $35.02M  !

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
CYP June 2025 Quarterly Activity Report and Appendix 4CPRICE SENSITIVE30/07/25 download Created with Sketch. 302.04KB
CYP CYP-001s FDA Approval Pathway Not ImpededPRICE SENSITIVE16/05/25 download Created with Sketch. 161.82KB
CYP March 2025 Quarterly Activity Report and Appendix 4CPRICE SENSITIVE24/04/25 download Created with Sketch. 404.91KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE27/02/25 download Created with Sketch. 852.38KB
CYP Publication comparing Cymerus MSCs to other MSCsPRICE SENSITIVE05/02/25 download Created with Sketch. 182.29KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/01/25 download Created with Sketch. 337.68KB
CYP First Kidney Transplant Trial Patient TreatedPRICE SENSITIVE12/12/24 download Created with Sketch. 192.51KB
CYP Cynata secures commitments for $8.1m institutional placementPRICE SENSITIVE06/12/24 download Created with Sketch. 182.05KB
CYP Demonstrated Safety & Efficacy in DFU Clinical TrialPRICE SENSITIVE05/12/24 download Created with Sketch. 2.37MB
CYP Trading HaltPRICE SENSITIVE04/12/24 download Created with Sketch. 321.74KB
CYP Cynata Receives $1.88m R&D Tax Incentive RefundPRICE SENSITIVE26/11/24 download Created with Sketch. 215.19KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE25/10/24 download Created with Sketch. 407.62KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE29/08/24 download Created with Sketch. 5.84MB
CYP Study of Cymerus MSCs in Pulmonary Fibrosis PublishedPRICE SENSITIVE08/08/24 download Created with Sketch. 183.38KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/07/24 download Created with Sketch. 290.82KB
CYP Cynata to Acquire IP from TekcytePRICE SENSITIVE01/07/24 download Created with Sketch. 145.6KB
CYP Further GvHD Clinical Data Published in Nature MedicinePRICE SENSITIVE22/05/24 download Created with Sketch. 163.8KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/04/24 download Created with Sketch. 325.82KB
CYP DFU Clinical Trial Enrolment CompletePRICE SENSITIVE08/04/24 download Created with Sketch. 141.17KB
CYP EU Approval for Phase 2 CYP-001 Trial in GvHDPRICE SENSITIVE20/03/24 download Created with Sketch. 151.52KB
CYP First Patient Treated in Phase 2 GvHD TrialPRICE SENSITIVE05/03/24 download Created with Sketch. 154.43KB
CYP Encouraging Initial Data from CYP-006TK DFU TrialPRICE SENSITIVE26/02/24 download Created with Sketch. 161.15KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE23/02/24 download Created with Sketch. 828KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/01/24 download Created with Sketch. 442.87KB
CYP Recruitment Completed in Phase 3 OA Clinical TrialPRICE SENSITIVE13/12/23 download Created with Sketch. 200.67KB
CYP Phase 2 Trial of CYP-001 in aGvHD Approved in TurkeyPRICE SENSITIVE07/12/23 download Created with Sketch. 198.02KB
CYP Cynata Receives $2.315m R&D Tax Incentive RefundPRICE SENSITIVE14/11/23 download Created with Sketch. 189.19KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE26/10/23 download Created with Sketch. 451.39KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE28/08/23 download Created with Sketch. 8.83MB
CYP Approval of Clinical Trial of CYP-001 in Kidney TransplantPRICE SENSITIVE21/08/23 download Created with Sketch. 226.05KB
CYP Phase 2 Trial of CYP-001 in aGvHD Open for RecruitmentPRICE SENSITIVE10/08/23 download Created with Sketch. 224.51KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE26/07/23 download Created with Sketch. 479.33KB
CYP Strategic Review of Cynata Clinical Development PortfolioPRICE SENSITIVE24/07/23 download Created with Sketch. 241.32KB
CYP Cynata announces CEO succession and Board changesPRICE SENSITIVE30/06/23 download Created with Sketch. 274.49KB
CYP Cynata Completes Oversubscribed Share Purchase PlanPRICE SENSITIVE10/05/23 download Created with Sketch. 240.96KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/04/23 download Created with Sketch. 479.44KB
CYP Share Purchase Plan Booklet & Option ProspectusPRICE SENSITIVE19/04/23 download Created with Sketch. 994.13KB
CYP Ethics Committee Approval for Proposed aGvHD Phase 2 TrialPRICE SENSITIVE12/04/23 download Created with Sketch. 250.35KB
CYP Capital Raising PresentationPRICE SENSITIVE06/04/23 download Created with Sketch. 3.23MB
CYP Cynata completes $5.0m Placement and launches SPPPRICE SENSITIVE06/04/23 download Created with Sketch. 299.75KB
CYP Trading HaltPRICE SENSITIVE04/04/23 download Created with Sketch. 298.18KB
CYP Cynata Adds New Sites for DFU Clinical TrialPRICE SENSITIVE16/03/23 download Created with Sketch. 260.1KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE28/02/23 download Created with Sketch. 815.32KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE31/01/23 download Created with Sketch. 507.29KB
CYP Cynata Receives IRB Approval for aGvHD Clinical TrialPRICE SENSITIVE30/01/23 download Created with Sketch. 252.05KB
CYP Notice of Acceptance for Cynata Australian PatentPRICE SENSITIVE09/01/23 download Created with Sketch. 249.94KB
CYP Cynata Receives $1.65m R&D Tax Incentive RefundPRICE SENSITIVE05/12/22 download Created with Sketch. 219.83KB
CYP Notice of Allowance for Cynata US PatentPRICE SENSITIVE11/11/22 download Created with Sketch. 249.75KB
CYP New Kidney Transplantation Clinical Trial for Cynata & LUMCPRICE SENSITIVE02/11/22 download Created with Sketch. 285.68KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE31/10/22 download Created with Sketch. 509.47KB
CYP Notice of Allowance for Australia & Canada Cymerus PatentsPRICE SENSITIVE17/10/22 download Created with Sketch. 249.47KB
CYP Successful Completion of Planned DSMB Review of DFU TrialPRICE SENSITIVE12/10/22 download Created with Sketch. 257.57KB
CYP Grant Award to Fund Study of Cynata MSCs in Heart DiseasePRICE SENSITIVE26/09/22 download Created with Sketch. 281.79KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE24/08/22 download Created with Sketch. 6.67MB
CYP Pipeline Update Following Strategic Portfolio ReviewPRICE SENSITIVE12/08/22 download Created with Sketch. 309.54KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/07/22 download Created with Sketch. 479.1KB
CYP Notice of Allowance for Cynata US PatentPRICE SENSITIVE14/07/22 download Created with Sketch. 251.63KB
CYP Further data supports potency of Cynata MSCsPRICE SENSITIVE14/06/22 download Created with Sketch. 277.96KB
CYP FDA Clears Cynata IND for Phase 2 Trial in GvHDPRICE SENSITIVE26/05/22 download Created with Sketch. 308.4KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/04/22 download Created with Sketch. 457.17KB
CYP Notice of Allowance for Cynata Chinese PatentPRICE SENSITIVE28/02/22 download Created with Sketch. 248.65KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/22 download Created with Sketch. 1.1MB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/01/22 download Created with Sketch. 489.79KB
CYP Cynata Receives Decision to Grant a Patent in JapanPRICE SENSITIVE27/01/22 download Created with Sketch. 248.67KB
CYP FUJIFILM Cellular Dynamics Executes Manufacturing AgreementPRICE SENSITIVE29/12/21 download Created with Sketch. 253.58KB
CYP Cynata Commences DFU Clinical TrialPRICE SENSITIVE22/12/21 download Created with Sketch. 258.16KB
CYP Site Initiation Visit Completed for CYP DFU Clinical TrialPRICE SENSITIVE18/11/21 download Created with Sketch. 261.46KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/10/21 download Created with Sketch. 496.46KB
CYP Cynata Receives US$5m Fujifilm FeePRICE SENSITIVE18/10/21 download Created with Sketch. 219.76KB
CYP DSMB Recommends Continuation of Cynata's MEND TrialPRICE SENSITIVE08/10/21 download Created with Sketch. 259.53KB
CYP Cynata Enters into a New Strategic Partnership with FujifilmPRICE SENSITIVE30/09/21 download Created with Sketch. 276.88KB
CYP Further Patents for Cynata Unique Cymerus TechnologyPRICE SENSITIVE15/09/21 download Created with Sketch. 251.78KB
CYP Further Canadian Patent for CynataPRICE SENSITIVE31/08/21 download Created with Sketch. 250.76KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE30/08/21 download Created with Sketch. 11.79MB
CYP Cynata Receives Notice of Allowance from US Patent OfficePRICE SENSITIVE26/08/21 download Created with Sketch. 194.84KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/07/21 download Created with Sketch. 363.27KB
CYP Ethics Approval for Cynata's Clinical Trial in DFUPRICE SENSITIVE30/06/21 download Created with Sketch. 622.16KB
CYP Progress Toward Clinical Trial in Diabetic Foot UlcersPRICE SENSITIVE28/06/21 download Created with Sketch. 165.1KB
CYP Cynata signs Licence Agreement with TekCytePRICE SENSITIVE03/06/21 download Created with Sketch. 202.54KB
CYP First Patient Enrolled in Cynata MEND Clinical TrialPRICE SENSITIVE24/05/21 download Created with Sketch. 207.31KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/04/21 download Created with Sketch. 331.3KB
CYP Cynata Expands trial in COVID-19 & Respiratory FailurePRICE SENSITIVE29/03/21 download Created with Sketch. 1.75MB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/21 download Created with Sketch. 767.33KB
CYP Cynata Receives $1.39m R&D Tax Incentive RefundPRICE SENSITIVE22/02/21 download Created with Sketch. 162.94KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/01/21 download Created with Sketch. 300.45KB
CYP Completion of Entitlement Offer and Shortfall PlacementPRICE SENSITIVE18/01/21 download Created with Sketch. 204.04KB
CYP Offer Booklet and Entitlement & Acceptance FormPRICE SENSITIVE21/12/20 download Created with Sketch. 11.91MB
CYP Investor PresentationPRICE SENSITIVE11/12/20 download Created with Sketch. 997.27KB
CYP CYP Closes $15m Institutional Placement to Expand PipelinePRICE SENSITIVE11/12/20 download Created with Sketch. 230.55KB
CYP Trading HaltPRICE SENSITIVE09/12/20 download Created with Sketch. 200.58KB
CYP Phase 3 Osteoarthritis Clinical Trial CommencesPRICE SENSITIVE11/11/20 download Created with Sketch. 1.7MB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/10/20 download Created with Sketch. 260.25KB
CYP Potential Utility of Cymerus MSCs in Heart Attack ModelPRICE SENSITIVE24/09/20 download Created with Sketch. 205.21KB
CYP Cymerus MSCs Effective in Preclinical Lung Disease StudyPRICE SENSITIVE07/09/20 download Created with Sketch. 208.88KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE25/08/20 download Created with Sketch. 1.98MB
CYP Patient Enrolment Opens in COVID-19 Clinical TrialPRICE SENSITIVE24/08/20 download Created with Sketch. 194.2KB
CYP Cynata Appoints Dr Geoff Brooke as ChairmanPRICE SENSITIVE18/08/20 download Created with Sketch. 211.81KB
CYP Cynata Announces Positive Results from GvHD Trial Follow-upPRICE SENSITIVE30/07/20 download Created with Sketch. 215.76KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/07/20 download Created with Sketch. 330.6KB
CYP Ethics Approval & Expedited Pathway for Phase 3 OA TrialPRICE SENSITIVE18/06/20 download Created with Sketch. 211.79KB
CYP June 2025 Quarterly Activity Report and Appendix 4C
30/07/25PRICE SENSITIVE download Created with Sketch. 302.04KB
CYP CYP-001s FDA Approval Pathway Not Impeded
16/05/25PRICE SENSITIVE download Created with Sketch. 161.82KB
CYP March 2025 Quarterly Activity Report and Appendix 4C
24/04/25PRICE SENSITIVE download Created with Sketch. 404.91KB
CYP Appendix 4D & Half-Year Financial Statements
27/02/25PRICE SENSITIVE download Created with Sketch. 852.38KB
CYP Publication comparing Cymerus MSCs to other MSCs
05/02/25PRICE SENSITIVE download Created with Sketch. 182.29KB
CYP Quarterly Activity Report & Appendix 4C
30/01/25PRICE SENSITIVE download Created with Sketch. 337.68KB
CYP First Kidney Transplant Trial Patient Treated
12/12/24PRICE SENSITIVE download Created with Sketch. 192.51KB
CYP Cynata secures commitments for $8.1m institutional placement
06/12/24PRICE SENSITIVE download Created with Sketch. 182.05KB
CYP Demonstrated Safety & Efficacy in DFU Clinical Trial
05/12/24PRICE SENSITIVE download Created with Sketch. 2.37MB
CYP Trading Halt
04/12/24PRICE SENSITIVE download Created with Sketch. 321.74KB
CYP Cynata Receives $1.88m R&D Tax Incentive Refund
26/11/24PRICE SENSITIVE download Created with Sketch. 215.19KB
CYP Quarterly Activity Report & Appendix 4C
25/10/24PRICE SENSITIVE download Created with Sketch. 407.62KB
CYP Appendix 4E & Annual Report
29/08/24PRICE SENSITIVE download Created with Sketch. 5.84MB
CYP Study of Cymerus MSCs in Pulmonary Fibrosis Published
08/08/24PRICE SENSITIVE download Created with Sketch. 183.38KB
CYP Quarterly Activity Report & Appendix 4C
30/07/24PRICE SENSITIVE download Created with Sketch. 290.82KB
CYP Cynata to Acquire IP from Tekcyte
01/07/24PRICE SENSITIVE download Created with Sketch. 145.6KB
CYP Further GvHD Clinical Data Published in Nature Medicine
22/05/24PRICE SENSITIVE download Created with Sketch. 163.8KB
CYP Quarterly Activity Report & Appendix 4C
30/04/24PRICE SENSITIVE download Created with Sketch. 325.82KB
CYP DFU Clinical Trial Enrolment Complete
08/04/24PRICE SENSITIVE download Created with Sketch. 141.17KB
CYP EU Approval for Phase 2 CYP-001 Trial in GvHD
20/03/24PRICE SENSITIVE download Created with Sketch. 151.52KB
CYP First Patient Treated in Phase 2 GvHD Trial
05/03/24PRICE SENSITIVE download Created with Sketch. 154.43KB
CYP Encouraging Initial Data from CYP-006TK DFU Trial
26/02/24PRICE SENSITIVE download Created with Sketch. 161.15KB
CYP Appendix 4D & Half-Year Financial Statements
23/02/24PRICE SENSITIVE download Created with Sketch. 828KB
CYP Quarterly Activity Report & Appendix 4C
30/01/24PRICE SENSITIVE download Created with Sketch. 442.87KB
CYP Recruitment Completed in Phase 3 OA Clinical Trial
13/12/23PRICE SENSITIVE download Created with Sketch. 200.67KB
CYP Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey
07/12/23PRICE SENSITIVE download Created with Sketch. 198.02KB
CYP Cynata Receives $2.315m R&D Tax Incentive Refund
14/11/23PRICE SENSITIVE download Created with Sketch. 189.19KB
CYP Quarterly Activity Report & Appendix 4C
26/10/23PRICE SENSITIVE download Created with Sketch. 451.39KB
CYP Appendix 4E & Annual Report
28/08/23PRICE SENSITIVE download Created with Sketch. 8.83MB
CYP Approval of Clinical Trial of CYP-001 in Kidney Transplant
21/08/23PRICE SENSITIVE download Created with Sketch. 226.05KB
CYP Phase 2 Trial of CYP-001 in aGvHD Open for Recruitment
10/08/23PRICE SENSITIVE download Created with Sketch. 224.51KB
CYP Quarterly Activity Report & Appendix 4C
26/07/23PRICE SENSITIVE download Created with Sketch. 479.33KB
CYP Strategic Review of Cynata Clinical Development Portfolio
24/07/23PRICE SENSITIVE download Created with Sketch. 241.32KB
CYP Cynata announces CEO succession and Board changes
30/06/23PRICE SENSITIVE download Created with Sketch. 274.49KB
CYP Cynata Completes Oversubscribed Share Purchase Plan
10/05/23PRICE SENSITIVE download Created with Sketch. 240.96KB
CYP Quarterly Activity Report & Appendix 4C
28/04/23PRICE SENSITIVE download Created with Sketch. 479.44KB
CYP Share Purchase Plan Booklet & Option Prospectus
19/04/23PRICE SENSITIVE download Created with Sketch. 994.13KB
CYP Ethics Committee Approval for Proposed aGvHD Phase 2 Trial
12/04/23PRICE SENSITIVE download Created with Sketch. 250.35KB
CYP Capital Raising Presentation
06/04/23PRICE SENSITIVE download Created with Sketch. 3.23MB
CYP Cynata completes $5.0m Placement and launches SPP
06/04/23PRICE SENSITIVE download Created with Sketch. 299.75KB
CYP Trading Halt
04/04/23PRICE SENSITIVE download Created with Sketch. 298.18KB
CYP Cynata Adds New Sites for DFU Clinical Trial
16/03/23PRICE SENSITIVE download Created with Sketch. 260.1KB
CYP Appendix 4D & Half-Year Financial Statements
28/02/23PRICE SENSITIVE download Created with Sketch. 815.32KB
CYP Quarterly Activity Report & Appendix 4C
31/01/23PRICE SENSITIVE download Created with Sketch. 507.29KB
CYP Cynata Receives IRB Approval for aGvHD Clinical Trial
30/01/23PRICE SENSITIVE download Created with Sketch. 252.05KB
CYP Notice of Acceptance for Cynata Australian Patent
09/01/23PRICE SENSITIVE download Created with Sketch. 249.94KB
CYP Cynata Receives $1.65m R&D Tax Incentive Refund
05/12/22PRICE SENSITIVE download Created with Sketch. 219.83KB
CYP Notice of Allowance for Cynata US Patent
11/11/22PRICE SENSITIVE download Created with Sketch. 249.75KB
CYP New Kidney Transplantation Clinical Trial for Cynata & LUMC
02/11/22PRICE SENSITIVE download Created with Sketch. 285.68KB
CYP Quarterly Activity Report & Appendix 4C
31/10/22PRICE SENSITIVE download Created with Sketch. 509.47KB
CYP Notice of Allowance for Australia & Canada Cymerus Patents
17/10/22PRICE SENSITIVE download Created with Sketch. 249.47KB
CYP Successful Completion of Planned DSMB Review of DFU Trial
12/10/22PRICE SENSITIVE download Created with Sketch. 257.57KB
CYP Grant Award to Fund Study of Cynata MSCs in Heart Disease
26/09/22PRICE SENSITIVE download Created with Sketch. 281.79KB
CYP Appendix 4E & Annual Report
24/08/22PRICE SENSITIVE download Created with Sketch. 6.67MB
CYP Pipeline Update Following Strategic Portfolio Review
12/08/22PRICE SENSITIVE download Created with Sketch. 309.54KB
CYP Quarterly Activity Report & Appendix 4C
27/07/22PRICE SENSITIVE download Created with Sketch. 479.1KB
CYP Notice of Allowance for Cynata US Patent
14/07/22PRICE SENSITIVE download Created with Sketch. 251.63KB
CYP Further data supports potency of Cynata MSCs
14/06/22PRICE SENSITIVE download Created with Sketch. 277.96KB
CYP FDA Clears Cynata IND for Phase 2 Trial in GvHD
26/05/22PRICE SENSITIVE download Created with Sketch. 308.4KB
CYP Quarterly Activity Report & Appendix 4C
29/04/22PRICE SENSITIVE download Created with Sketch. 457.17KB
CYP Notice of Allowance for Cynata Chinese Patent
28/02/22PRICE SENSITIVE download Created with Sketch. 248.65KB
CYP Appendix 4D & Half-Year Financial Statements
25/02/22PRICE SENSITIVE download Created with Sketch. 1.1MB
CYP Quarterly Activity Report & Appendix 4C
28/01/22PRICE SENSITIVE download Created with Sketch. 489.79KB
CYP Cynata Receives Decision to Grant a Patent in Japan
27/01/22PRICE SENSITIVE download Created with Sketch. 248.67KB
CYP FUJIFILM Cellular Dynamics Executes Manufacturing Agreement
29/12/21PRICE SENSITIVE download Created with Sketch. 253.58KB
CYP Cynata Commences DFU Clinical Trial
22/12/21PRICE SENSITIVE download Created with Sketch. 258.16KB
CYP Site Initiation Visit Completed for CYP DFU Clinical Trial
18/11/21PRICE SENSITIVE download Created with Sketch. 261.46KB
CYP Quarterly Activity Report & Appendix 4C
28/10/21PRICE SENSITIVE download Created with Sketch. 496.46KB
CYP Cynata Receives US$5m Fujifilm Fee
18/10/21PRICE SENSITIVE download Created with Sketch. 219.76KB
CYP DSMB Recommends Continuation of Cynata's MEND Trial
08/10/21PRICE SENSITIVE download Created with Sketch. 259.53KB
CYP Cynata Enters into a New Strategic Partnership with Fujifilm
30/09/21PRICE SENSITIVE download Created with Sketch. 276.88KB
CYP Further Patents for Cynata Unique Cymerus Technology
15/09/21PRICE SENSITIVE download Created with Sketch. 251.78KB
CYP Further Canadian Patent for Cynata
31/08/21PRICE SENSITIVE download Created with Sketch. 250.76KB
CYP Appendix 4E & Annual Report
30/08/21PRICE SENSITIVE download Created with Sketch. 11.79MB
CYP Cynata Receives Notice of Allowance from US Patent Office
26/08/21PRICE SENSITIVE download Created with Sketch. 194.84KB
CYP Quarterly Activity Report & Appendix 4C
28/07/21PRICE SENSITIVE download Created with Sketch. 363.27KB
CYP Ethics Approval for Cynata's Clinical Trial in DFU
30/06/21PRICE SENSITIVE download Created with Sketch. 622.16KB
CYP Progress Toward Clinical Trial in Diabetic Foot Ulcers
28/06/21PRICE SENSITIVE download Created with Sketch. 165.1KB
CYP Cynata signs Licence Agreement with TekCyte
03/06/21PRICE SENSITIVE download Created with Sketch. 202.54KB
CYP First Patient Enrolled in Cynata MEND Clinical Trial
24/05/21PRICE SENSITIVE download Created with Sketch. 207.31KB
CYP Quarterly Activity Report & Appendix 4C
28/04/21PRICE SENSITIVE download Created with Sketch. 331.3KB
CYP Cynata Expands trial in COVID-19 & Respiratory Failure
29/03/21PRICE SENSITIVE download Created with Sketch. 1.75MB
CYP Appendix 4D & Half-Year Financial Statements
25/02/21PRICE SENSITIVE download Created with Sketch. 767.33KB
CYP Cynata Receives $1.39m R&D Tax Incentive Refund
22/02/21PRICE SENSITIVE download Created with Sketch. 162.94KB
CYP Quarterly Activity Report & Appendix 4C
29/01/21PRICE SENSITIVE download Created with Sketch. 300.45KB
CYP Completion of Entitlement Offer and Shortfall Placement
18/01/21PRICE SENSITIVE download Created with Sketch. 204.04KB
CYP Offer Booklet and Entitlement & Acceptance Form
21/12/20PRICE SENSITIVE download Created with Sketch. 11.91MB
CYP Investor Presentation
11/12/20PRICE SENSITIVE download Created with Sketch. 997.27KB
CYP CYP Closes $15m Institutional Placement to Expand Pipeline
11/12/20PRICE SENSITIVE download Created with Sketch. 230.55KB
CYP Trading Halt
09/12/20PRICE SENSITIVE download Created with Sketch. 200.58KB
CYP Phase 3 Osteoarthritis Clinical Trial Commences
11/11/20PRICE SENSITIVE download Created with Sketch. 1.7MB
CYP Quarterly Activity Report & Appendix 4C
30/10/20PRICE SENSITIVE download Created with Sketch. 260.25KB
CYP Potential Utility of Cymerus MSCs in Heart Attack Model
24/09/20PRICE SENSITIVE download Created with Sketch. 205.21KB
CYP Cymerus MSCs Effective in Preclinical Lung Disease Study
07/09/20PRICE SENSITIVE download Created with Sketch. 208.88KB
CYP Appendix 4E & Annual Report
25/08/20PRICE SENSITIVE download Created with Sketch. 1.98MB
CYP Patient Enrolment Opens in COVID-19 Clinical Trial
24/08/20PRICE SENSITIVE download Created with Sketch. 194.2KB
CYP Cynata Appoints Dr Geoff Brooke as Chairman
18/08/20PRICE SENSITIVE download Created with Sketch. 211.81KB
CYP Cynata Announces Positive Results from GvHD Trial Follow-up
30/07/20PRICE SENSITIVE download Created with Sketch. 215.76KB
CYP Quarterly Activity Report & Appendix 4C
28/07/20PRICE SENSITIVE download Created with Sketch. 330.6KB
CYP Ethics Approval & Expedited Pathway for Phase 3 OA Trial
18/06/20PRICE SENSITIVE download Created with Sketch. 211.79KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
15.5¢
Change
-0.015(8.82%)
Mkt cap ! $35.02M
Open High Low Value Volume
17.0¢ 17.0¢ 15.5¢ $35.01K 213.1K

Buyers (Bids)

No. Vol. Price($)
4 201289 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 14675 1
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
Last
15.5¢
  Change
-0.015 ( 8.82 %)
Open High Low Volume
17.3¢ 17.3¢ 15.5¢ 186445
Last updated 15.55pm 31/07/2025 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.